Bank of New York Mellon’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
366,352
+17,555
| +5% | +$54.2K | ﹤0.01% | 3055 |
|
|
2025
Q1 | $1.22M | Sell |
348,797
-4,577
| -1% | -$16K | ﹤0.01% | 2931 |
|
|
2024
Q4 | $1.16M | Buy |
353,374
+803
| +0.2% | +$2.63K | ﹤0.01% | 3046 |
|
|
2024
Q3 | $1.36M | Sell |
352,571
-141,158
| -29% | -$543K | ﹤0.01% | 2958 |
|
|
2024
Q2 | $1.53M | Buy |
493,729
+86,104
| +21% | +$266K | ﹤0.01% | 2948 |
|
|
2024
Q1 | $1.05M | Sell |
407,625
-49,203
| -11% | -$127K | ﹤0.01% | 3121 |
|
|
2023
Q4 | $1.14M | Buy |
456,828
+5,361
| +1% | +$13.4K | ﹤0.01% | 3117 |
|
|
2023
Q3 | $916K | Buy |
451,467
+850
| +0.2% | +$1.73K | ﹤0.01% | 3202 |
|
|
2023
Q2 | $1.04M | Buy |
450,617
+27,936
| +7% | +$64.3K | ﹤0.01% | 3174 |
|
|
2023
Q1 | $1.28M | Buy |
422,681
+4,154
| +1% | +$12.6K | ﹤0.01% | 3032 |
|
|
2022
Q4 | $975K | Buy |
418,527
+33,066
| +9% | +$77K | ﹤0.01% | 3201 |
|
|
2022
Q3 | $736K | Buy |
385,461
+30,612
| +9% | +$58.5K | ﹤0.01% | 3357 |
|
|
2022
Q2 | $962K | Sell |
354,849
-12,340
| -3% | -$33.5K | ﹤0.01% | 3232 |
|
|
2022
Q1 | $1.09M | Buy |
367,189
+14,236
| +4% | +$42.4K | ﹤0.01% | 3251 |
|
|
2021
Q4 | $1.37M | Buy |
352,953
+96,032
| +37% | +$374K | ﹤0.01% | 3202 |
|
|
2021
Q3 | $1.1M | Buy |
256,921
+16,929
| +7% | +$72.6K | ﹤0.01% | 3334 |
|
|
2021
Q2 | $727K | Buy |
239,992
+188,576
| +367% | +$571K | ﹤0.01% | 3587 |
|
|
2021
Q1 | $171K | Sell |
51,416
-4,898
| -9% | -$16.3K | ﹤0.01% | 4091 |
|
|
2020
Q4 | $200K | Buy |
56,314
+38,577
| +217% | +$137K | ﹤0.01% | 3975 |
|
|
2020
Q3 | $56K | Buy |
+17,737
| New | +$56K | ﹤0.01% | 4007 |
|
|
2020
Q1 | – | Sell |
-256,327
| Closed | -$713K | – | 4093 |
|
|
2019
Q4 | $713K | Hold |
256,327
| – | – | ﹤0.01% | 3399 |
|
|
2019
Q3 | $391K | Buy |
+256,327
| New | +$391K | ﹤0.01% | 3677 |
|
|
2019
Q2 | – | Sell |
-97,968
| Closed | -$350K | – | 4198 |
|
|
2019
Q1 | $350K | Buy |
97,968
+5,686
| +6% | +$20.3K | ﹤0.01% | 3683 |
|
|
2018
Q4 | $353K | Sell |
92,282
-99,575
| -52% | -$381K | ﹤0.01% | 3642 |
|
|
2018
Q3 | $1.81M | Buy |
191,857
+108,398
| +130% | +$1.02M | ﹤0.01% | 2893 |
|
|
2018
Q2 | $609K | Buy |
+83,459
| New | +$609K | ﹤0.01% | 3529 |
|